ExodusPoint Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-3,384
Closed -$1.82M – 1983
2026
Q2
$1.82M Sell
3,384
-2,186
-39% -$1.12M 0.01% 859
2026
Q1
$2.92M Buy
+5,570
New +$2.66M 0.02% 629
2025
Q3
– Sell
-2,878
Closed -$871K – 1830
2025
Q2
$871K Buy
+2,878
New +$857K 0.01% 1000
2024
Q4
– Sell
-2,645
Closed -$561K – 1830
2024
Q3
$561K Buy
+2,645
New +$677K ﹤0.01% 1151
2023
Q4
– Sell
-8,162
Closed -$1.19M – 1819
2023
Q3
$1.19M Buy
+8,162
New +$1.54M 0.01% 902
2023
Q2
– Sell
-1,060
Closed -$257K – 2095
2023
Q1
$257K Buy
+1,060
New +$289K ﹤0.01% 1510
2022
Q4
– Sell
-9,177
Closed -$596K – 1926
2022
Q3
$596K Buy
9,177
+5,388
+142% +$374K 0.01% 1302
2022
Q2
$271K Buy
+3,789
New +$279K ﹤0.01% 1568
2020
Q4
– Sell
-2,089
Closed -$248K – 2208
2020
Q3
$248K Buy
+2,089
New +$227K ﹤0.01% 1375

Other funds holding MDGL

ExodusPoint Capital Management's MDGL Position: Q3 2026 in Review

ExodusPoint Capital Management sold out of Madrigal Pharmaceuticals (MDGL) in Q3 2026, closing a stake of 3,384 shares — an estimated $1.82M sold.

ExodusPoint Capital Management first reported a position in MDGL in Q3 2020 and held it in 9 quarters. The position peaked at $2.92M in Q1 2026. 440 funds tracked by Wall St. Rank hold MDGL as of Q3 2026.

  • ExodusPoint Capital Management reported no remaining Madrigal Pharmaceuticals position as of Q3 2026 after selling out during the quarter.
  • ExodusPoint Capital Management sold 3,384 Madrigal Pharmaceuticals shares in Q3 2026, an estimated $1.82M.
  • ExodusPoint Capital Management first reported a position in Madrigal Pharmaceuticals in Q3 2020 and held it in 9 quarters.
  • ExodusPoint Capital Management's Madrigal Pharmaceuticals position peaked at $2.92M in Q1 2026.
  • 440 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q3 2026.

Based on ExodusPoint Capital Management's 13F filing for Q3 2026, filed 16 Nov 2026.